Sanofi stock rose nearly 7% ... Both UC and CD indications are primary forms of IBD, marked by chronic inflammation in the gastrointestinal tract. In recent years, there has been a surge in ...
Sanofi stock rose nearly 7%. Year to date, the stock fell 1.6% against the industry’s 5.3% growth. Zacks Investment Research Image Source: Zacks Investment Research Shares of Teva jumped 26% ...
Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Sam Slutsky’s rating is based ...